Meritage Portfolio Management’s Edwards Lifesciences EW Stock Holding History

Meritage Portfolio Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-256,020	Closed	-$6.07M	–	202
2015 Q3	$6.07M	Buy	256,020 +8,850	+4%	+$214K	0.7%	40
2015 Q2	$5.87M	Buy	247,170 +1,950	+0.8%	+$44K	0.62%	56
2015 Q1	$5.82M	Sell	245,220 -263,850	-52%	-$5.92M	0.58%	65
2014 Q4	$10.8M	Sell	509,070 -7,200	-1%	-$145K	1.15%	8
2014 Q3	$8.79M	Sell	516,270 -13,950	-3%	-$220K	1%	9
2014 Q2	$7.59M	Buy	530,220 +7,440	+1%	+$101K	0.83%	15
2014 Q1	$6.46M	Buy	522,780 +8,430	+2%	+$97.3K	0.78%	26
2013 Q4	$5.64M	Sell	514,350 -24,060	-4%	-$271K	0.7%	45
2013 Q3	$6.25M	Buy	+538,410	New	+$6.3M	0.81%	25

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Meritage Portfolio Management's EW Position: Q4 2015 in Review

Meritage Portfolio Management sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 256,020 shares — an estimated $6.07M sold.

Meritage Portfolio Management first reported a position in EW in Q3 2013 and held it in 9 quarters. The position peaked at $10.8M in Q4 2014. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

Meritage Portfolio Management reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
Meritage Portfolio Management sold 256,020 Edwards Lifesciences shares in Q4 2015, an estimated $6.07M.
Meritage Portfolio Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 9 quarters.
Meritage Portfolio Management's Edwards Lifesciences position peaked at $10.8M in Q4 2014.
605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Meritage Portfolio Management's 13F filing for Q4 2015, filed 3 Feb 2016.